(Q40510881)

21 September 2017

title

Rituximab induces different but overlapping sets of genes in human B-lymphoma cell lines (English)

1 reference

21 September 2017

1 reference

4

1 reference

21 September 2017

Elena Cittera

1

1 reference

21 September 2017

Chiara Onofri

2

1 reference

21 September 2017

Maria D'Apolito

3

1 reference

21 September 2017

Giovanni Cazzaniga

5

1 reference

21 September 2017

Leopoldo Zelante

6

1 reference

21 September 2017

Paolo Paolucci

7

1 reference

21 September 2017

Andrea Biondi

8

1 reference

21 September 2017

Martino Introna

9

1 reference

21 September 2017

Josée Golay

10

1 reference

21 September 2017

publication date

23 September 2004

1 reference

Cancer Immunology, Immunotherapy

21 September 2017

published in

1 reference

21 September 2017

volume

54

1 reference

21 September 2017

issue

3

1 reference

21 September 2017

page(s)

273-286

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-004-0599-4

21 September 2017

exact match

0 references

cites work

Complement activation determines the therapeutic activity of rituximab in vivo.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0599-4

Activation of the mitogen-activated protein kinase pathway induces transcription of the PAC-1 phosphatase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0599-4

Characterization of cytokine LD78 gene promoters: positive and negative transcriptional factors bind to a negative regulatory element common to LD78, interleukin-3, and granulocyte-macrophage colony-stimulating factor gene promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0599-4

Colocalization of the B cell receptor and CD20 followed by activation-dependent dissociation in distinct lipid rafts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0599-4

Inhibition of the MEK/ERK signaling pathway blocks a subset of B cell responses to antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0599-4

Growth inhibition of CD20-positive B lymphoma cell lines by IDEC-C2B8 anti-CD20 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-004-0599-4

10.1007/S00262-004-0599-4

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

21 September 2017

1041568353

0 references

1 reference